KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for BeOne Medicines (ONC) over the last 6 years, with Dec 2024 value amounting to -$0.47.

  • BeOne Medicines' EPS (Weighted Average and Diluted) rose 188.89% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.03, marking a year-over-year increase of 104.82%. This contributed to the annual value of -$0.47 for FY2024, which is 27.69% up from last year.
  • Per BeOne Medicines' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.47 for FY2024, which was up 27.69% from -$0.65 recorded in FY2023.
  • In the past 5 years, BeOne Medicines' EPS (Weighted Average and Diluted) registered a high of -$0.47 during FY2024, and its lowest value of -$1.50 during FY2020.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.87, with a median of -$0.65 in 2023.
  • As far as peak fluctuations go, BeOne Medicines' EPS (Weighted Average and Diluted) decreased by 23.14% in 2022, and later spiked by 56.38% in 2023.
  • Over the past 5 years, BeOne Medicines' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.50 in 2020, then rose by 19.33% to -$1.21 in 2021, then dropped by 23.14% to -$1.49 in 2022, then spiked by 56.38% to -$0.65 in 2023, then rose by 27.69% to -$0.47 in 2024.